BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18386776)

  • 1. Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms (Br J Surg 2008; 95: 333-337).
    Fujita T
    Br J Surg; 2008 May; 95(5):667; author reply 667-8. PubMed ID: 18386776
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms.
    Abisi S; Burnand KG; Humphries J; Waltham M; Taylor P; Smith A
    Br J Surg; 2008 Mar; 95(3):333-7. PubMed ID: 17968978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
    Wilson WR; Evans J; Bell PR; Thompson MM
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):259-62. PubMed ID: 16009575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm.
    Gacko M; Chyczewski L; Chrostek L
    Pol J Pathol; 1999; 50(2):83-6. PubMed ID: 10481531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo study on the expression pattern of resistin in patients with abdominal aortic aneurysm.
    Muehling BM; Paintner A; Marx N; Barth TF; Babiak C; Orend KH
    Vasc Endovascular Surg; 2011 Jan; 45(1):63-8. PubMed ID: 20810407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms.
    Mateos-Cáceres PJ; López-Farré AJ; Morata PC; Ramos-Mozo P; Macaya C; Serrano FJ; Moñux G
    Can J Physiol Pharmacol; 2008 Jul; 86(7):431-7. PubMed ID: 18641692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in the pathogenesis of abdominal aortic aneurysms: a possible pathway for the effect of statins?
    Paraskevas KI; Andrikopoulou M; Anastasakis E; Perrea D; Mikhailidis DP
    Angiology; 2010 Feb; 61(2):226-7; author reply 227-8. PubMed ID: 19926623
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological treatment of abdominal aortic aneurysm.
    Miyake T; Morishita R
    Cardiovasc Res; 2009 Aug; 83(3):436-43. PubMed ID: 19454489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are statins an option in the management of abdominal aortic aneurysms?
    Paraskevas KI; Liapis CD; Hamilton G; Mikhailidis DP
    Vasc Endovascular Surg; 2008; 42(2):128-34. PubMed ID: 18421030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of statins on abdominal aortic aneurysm.
    Hosseini A; Sahranavard T; Reiner Ž; Jamialahmadi T; Dhaheri YA; Eid AH; Sahebkar A
    Eur J Pharm Sci; 2022 Nov; 178():106284. PubMed ID: 36038100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and abdominal aortic aneurysms.
    Cristofori R
    J Cardiovasc Surg (Torino); 2004 Dec; 45(6):590. PubMed ID: 15746644
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of proteolytic treatment on plastic deformation of porcine aortic tissue.
    Kratzberg JA; Walker PJ; Rikkers E; Raghavan ML
    J Mech Behav Biomed Mater; 2009 Jan; 2(1):65-72. PubMed ID: 19627809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Was the role of statins in slowing the progression of abdominal aortic aneurysms underestimated?
    Karrowni W; Miller FJ
    Am Heart J; 2011 May; 161(5):e29; author reply e31. PubMed ID: 21570503
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medical treatment of small abdominal aortic aneurysms].
    Høgh AL; Sandermann J; Lindholt JS
    Ugeskr Laeger; 2008 Jun; 170(23):2003-5. PubMed ID: 18534161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C deficiency in human atherosclerosis and aortic aneurysms.
    Shi GP; Sukhova GK; Grubb A; Ducharme A; Rhode LH; Lee RT; Ridker PM; Libby P; Chapman HA
    J Clin Invest; 1999 Nov; 104(9):1191-7. PubMed ID: 10545518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological therapy for patients with abdominal aortic aneurysm.
    Assar AN
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):999-1009. PubMed ID: 19673677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins: a sine qua non of the management of patients with abdominal aortic aneurysms.
    Paraskevas KI; Mikhailidis DP; Giannoukas AD
    Int J Cardiol; 2013 Oct; 168(4):4528. PubMed ID: 23871335
    [No Abstract]   [Full Text] [Related]  

  • 18. Statins suppress the development of aneurysms: fact or fiction?
    Paraskevas KI
    Stroke; 2008 Aug; 39(8):e134; author reply e135. PubMed ID: 18599806
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter by Paraskevas regarding article, "Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromso study".
    Paraskevas KI
    Circulation; 2010 Jan; 121(1):e6; author reply e8. PubMed ID: 20048230
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells.
    Lindeman JH; Abdul-Hussien H; van Bockel JH; Wolterbeek R; Kleemann R
    Circulation; 2009 Apr; 119(16):2209-16. PubMed ID: 19364980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.